Two Dose Level BOTOX Patients w/Urinary Incontinence

ID Number 07-0890

Principal Investigator(s)
Thomas N Bryce

Department(s) or Division(s)
Rehabilitation Medicine


The purpose of this study is to investigate the safety and effectiveness of each of two dosages of BOTOX® (200 U or 300 U) compared to placebo injected into the bladder in patients with incontinence due to neurogenic overactive bladder who have not been adequately managed with anticholinergic therapy.

Contact Information
Anousheh Behnegar
(212) 659-9379

Recruiting Patients: No